MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3

Abstract Objective To investigate the regulatory role of miR-223-3p in the inflammatory response of PE placenta. Methods PE and normal placental tissues were collected to measure the expression of NLRP3 and miR-223-3p. The targeting relationship between NLRP3 and miR-223-3P was verified by bioinform...

Full description

Bibliographic Details
Main Authors: Xueqiong Liu, Zhiyue Li, Dan Lu
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-024-06371-9
_version_ 1797266590285168640
author Xueqiong Liu
Zhiyue Li
Dan Lu
author_facet Xueqiong Liu
Zhiyue Li
Dan Lu
author_sort Xueqiong Liu
collection DOAJ
description Abstract Objective To investigate the regulatory role of miR-223-3p in the inflammatory response of PE placenta. Methods PE and normal placental tissues were collected to measure the expression of NLRP3 and miR-223-3p. The targeting relationship between NLRP3 and miR-223-3P was verified by bioinformatics analysis and classical double-luciferase reporter gene assay. Lipopolysaccharide (LPS) was used to induce HTR8/SVneo cells as PE placental cell inflammation model. Then we transfected miR-223-3p overexpression/miR-223-3p negative control plasmid into the LPS-induced HTR8/SVneo cells. Next, the expressions of NLRP3, Caspase-1, GSDMD, IL-1β and IL-18 were evaluated to elucidate the regulatory effect of miR-223-3p on the inflammatory response mediated by NLRP3 in PE placenta. Results Compared with normal controls, NLRP3 was significantly up-regulated in PE placenta, while miR-223-3p was down-regulated. In addition, NLRP3 was a direct target of miR-223-3p. Further research revealed that the expression of NLRP3, Caspase-1, GSDMD, IL-1β and IL-18 could be obviously promoted in HTR8/SVneo cells treated with LPS (500 ng/ml) for 24 h, nevertheless it could be significantly suppressesed under the overexpression of miR-223-3p. Conclusion MiR-223-3p suppressed NLRP3 inflamariomes activation, downstream inflammatory factors secretion and pyroptosis in LPS-induced HTR8/SVneo cells indicating that miR-223-3p could serve as an anti-inflammatory factor in preeclampsia.
first_indexed 2024-04-25T01:03:06Z
format Article
id doaj.art-c62e4ab56ece407da0394111efa7bc17
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-25T01:03:06Z
publishDate 2024-03-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-c62e4ab56ece407da0394111efa7bc172024-03-10T12:24:07ZengBMCBMC Pregnancy and Childbirth1471-23932024-03-0124111210.1186/s12884-024-06371-9MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3Xueqiong Liu0Zhiyue Li1Dan Lu2Clinical Medical College of Yangzhou UniversityClinical Medical College of Yangzhou UniversityClinical Medical College of Yangzhou UniversityAbstract Objective To investigate the regulatory role of miR-223-3p in the inflammatory response of PE placenta. Methods PE and normal placental tissues were collected to measure the expression of NLRP3 and miR-223-3p. The targeting relationship between NLRP3 and miR-223-3P was verified by bioinformatics analysis and classical double-luciferase reporter gene assay. Lipopolysaccharide (LPS) was used to induce HTR8/SVneo cells as PE placental cell inflammation model. Then we transfected miR-223-3p overexpression/miR-223-3p negative control plasmid into the LPS-induced HTR8/SVneo cells. Next, the expressions of NLRP3, Caspase-1, GSDMD, IL-1β and IL-18 were evaluated to elucidate the regulatory effect of miR-223-3p on the inflammatory response mediated by NLRP3 in PE placenta. Results Compared with normal controls, NLRP3 was significantly up-regulated in PE placenta, while miR-223-3p was down-regulated. In addition, NLRP3 was a direct target of miR-223-3p. Further research revealed that the expression of NLRP3, Caspase-1, GSDMD, IL-1β and IL-18 could be obviously promoted in HTR8/SVneo cells treated with LPS (500 ng/ml) for 24 h, nevertheless it could be significantly suppressesed under the overexpression of miR-223-3p. Conclusion MiR-223-3p suppressed NLRP3 inflamariomes activation, downstream inflammatory factors secretion and pyroptosis in LPS-induced HTR8/SVneo cells indicating that miR-223-3p could serve as an anti-inflammatory factor in preeclampsia.https://doi.org/10.1186/s12884-024-06371-9PreeclampsiaPlacenta inflammatory dysregulationNLRP3 inflammasomemicroRNA-223-3p
spellingShingle Xueqiong Liu
Zhiyue Li
Dan Lu
MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
BMC Pregnancy and Childbirth
Preeclampsia
Placenta inflammatory dysregulation
NLRP3 inflammasome
microRNA-223-3p
title MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
title_full MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
title_fullStr MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
title_full_unstemmed MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
title_short MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3
title_sort microrna 223 3p downregulates the inflammatory response in preeclampsia placenta via targeting nlrp3
topic Preeclampsia
Placenta inflammatory dysregulation
NLRP3 inflammasome
microRNA-223-3p
url https://doi.org/10.1186/s12884-024-06371-9
work_keys_str_mv AT xueqiongliu microrna2233pdownregulatestheinflammatoryresponseinpreeclampsiaplacentaviatargetingnlrp3
AT zhiyueli microrna2233pdownregulatestheinflammatoryresponseinpreeclampsiaplacentaviatargetingnlrp3
AT danlu microrna2233pdownregulatestheinflammatoryresponseinpreeclampsiaplacentaviatargetingnlrp3